サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：牛結核診断の世界市場：成長、将来展望、競合分析 (2024年～2032年)
市場調査レポート
商品コード
1642611

牛結核診断の世界市場：成長、将来展望、競合分析 (2024年～2032年)

Bovine Tuberculosis Diagnosis Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032

出版日
ページ情報
英文 179 Pages
納期
即日から翌営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
牛結核診断の世界市場：成長、将来展望、競合分析 (2024年～2032年)
出版日: 2024年11月13日
発行: Acute Market Reports
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

牛結核診断市場は、2024年から2032年の予測期間中にCAGR 7.7％で成長すると予測されています。牛結核（bTB）は、ヒトの結核の原因菌と近縁のMycobacterium bovisという細菌によって引き起こされる牛の慢性疾患です。この病気は、牛群間で急速に蔓延し、主に未殺菌乳や直接接触によって人にトランスミッションする可能性があるため、世界中の家畜に重大な影響を及ぼしています。bTBの診断は、この病気の効果的な管理と制御のために極めて重要であり、皮膚テスト、血液テスト、そしてPCRやインターフェロン-ガンマ放出アッセイのようなより高度な方法が含まれます。牛結核診断市場は、牛群の健康を維持し、貿易規制を遵守し、人獣共通感染症のトランスミッションを防止する必要性によって牽引されています。

促進要因

牛結核の罹患率の増加

世界の牛結核の罹患率の上昇は、診断市場の主な促進要因です。酪農や肉牛産業が盛んな地域、特に体系的な防疫プログラムが十分でない地域では、結核の感染率が高くなっています。このような感染率の増加により、感染拡大を防ぐために牛群内での定期的かつ広範な検査が必要となり、診断薬市場の成長を支えています。

規制強化と管理プログラム

各国政府や国際機関は、牛の定期的な結核検査を義務付ける厳しい規制や管理プログラムを実施しています。こうした規制の枠組みは、特に家畜の輸出が多い国々において、結核を管理し、最終的には根絶することを目的としています。例えば、欧州連合（EU）の包括的な撲滅プログラムでは、定期的な検査が義務付けられており、加盟国における診断検査の需要に大きな影響を与えています。

診断技術の進歩

分子診断や血清学的手法の強化など、より正確で迅速な診断法の開発が市場開拓の原動力となっています。これらの技術は、ツベルクリン皮膚テストのような従来の方法と比較して、迅速な結果と高い感度と特異性を提供します。日常的な獣医療に高度な診断法が統合されることで、結核の早期発見と管理が強化され、診断薬市場を前進させる。

阻害要因

診断検査の高コストと複雑さ

診断技術の進歩にもかかわらず、これらの検査に伴う高コストと複雑さが大きな阻害要因となっています。PCR検査や培養検査のような高度な診断法には高度な機器と熟練した人材が必要であり、農村部や過疎地では必ずしも利用できないです。特に家畜生産が重要な経済的役割を果たしながら、財源が限られている発展途上国では、こうした検査の経済的負担が普及を制限しています。この経済的要因は、牛結核診断市場の成長を大きく阻害しています。大規模で定期的な検査需要に対応するには、費用対効果の高いソリューションが依然として必要だからです。

試料の種類別市場セグメンテーション

牛結核診断市場は、試料の種類別に血液試料、鼻腔スワブ、組織試料、その他の試料に区分されます。血液試料は、採取が容易であり、高度な血清学的診断や分子生物学的診断を含むさまざまな検査に使用できるため、その感度と特異性で人気を集めており、年間平均成長率（CAGR）は最も高くなると予測されます。組織試料は、死後または生検で採取されることが多く、市場内で最も高い収益を上げると予想されます。これは、培養検査や病理組織検査による確定診断において重要な役割を果たすためであり、侵襲的で高度な取り扱いを必要とするにもかかわらず、疾患の決定的な証拠を提供します。牛結核が疑われる症例における正確な診断の必要性が、これらの試料タイプの需要を牽引しており、市場収益における大きなシェアを反映しています。全体として、これらの検体を用いた検査の効率と精度を高める診断技術の進歩は、これらの検体の採用と市場での成長を促進する上で極めて重要です。

最終用途別市場セグメンテーション

最終用途別では、牛結核診断市場は動物病院、研究機関、獣医用診断検査室、畜産農場・牧場に分類されます。獣医用診断検査室は、多様な種類の試料の取り扱いと分析に特化した能力を持ち、疾病サーベイランスとアウトブレイク対応において重要な役割を担っていることから、CAGRの面でリードすると予測されています。畜産農場と牧場は、最も高い収益セグメントを占めると予測されています。このセグメントの優位性は、経済的な存続のために疾病のない牛群を維持することへの依存度が高く、継続的かつ広範な検査実施が義務付けられていることに起因しています。潜在的な伝染病の主要発生場所である農場と牧場は、伝染病の蔓延を防ぐために定期的な検査に多大な投資を行っており、これが市場の大幅な収益を牽引しています。畜産現場におけるポイント・オブ・ケアでの高度診断の統合は、成長しつつあるとはいえ、まだ十分に浸透しておらず、市場拡大の大きな可能性をもたらしています。このような動きは、牛の結核管理の広範なエコシステムにおける両分野の重要な役割を裏付けています。

地域別の洞察

牛結核診断市場の地理的セグメンテーションでは、地域によって異なる動向と差異が明らかになった。北米は、先進的な農業慣行、厳格な規制枠組み、人獣共通感染症に関する意識の高まりにより、年間平均成長率（CAGR）が最も高くなると予想されます。この地域は、包括的なサーベイランスと管理プログラムを通じて牛の結核管理に積極的な姿勢を示しており、その成長ダイナミクスに大きく寄与しています。逆に、アジア太平洋地域は市場で最も高い売上比率を占めると予想されています。インドや中国のような国々では家畜の数が多く、動物の健康基準を強化するための政府の取り組みが増加していることも相まって、市場収益の大きな原動力となっています。この地域は、乳製品と食肉製品の需要増に対応するため、家畜の生産性向上に重点を置いており、その優位な収益ポジションを確固たるものにしています。さらに、市場は新興国市場の規制、経済開発、技術導入パターンの影響を受けており、これらは欧州、ラテンアメリカ、中東・アフリカで大きく異なり、それぞれが成長の可能性と課題を異にする牛結核診断の世界情勢に貢献しています。

競合情勢

競合情勢は、Bio-Rad Laboratories社、Chembio Diagnostics社、Enfer社、IDEXX Laboratories社、IDVet社、LIONEX社、PBD Biotech社、QIAGEN社、Thermo Fisher Scientific社、ZENDAL社などの主要企業が、牛結核診断市場において激しく競合し、イノベーションを推進しています。これらの企業は、製品ポートフォリオの拡大、診断技術の進歩、パートナーシップや買収、研究開発投資の拡大による新規市場への参入に戦略的に注力しています。例えば、サーモフィッシャーサイエンティフィックは2022年、動物用医薬品ソリューション分野で大幅な増収を記録し、広範な販売網と技術力を活用して市場シェアを拡大しました。同様に、QIAGENは診断アッセイとプラットフォームの強化に積極的で、より正確で迅速な検査ソリューションの提供を目指しています。2024年から2032年までの予測期間には、これらの企業が診断精度の向上と納期短縮に向けた努力を継続することが予想されます。政府機関や地域の動物保健組織との連携、世界・ヘルス・プログラムへの参加といった戦略が極めて重要になると予想されます。また、デジタルツールやAIを診断に統合することが重視され、差別化された付加価値の高いサービスを世界中の動物病院に提供しようとする企業の競争戦略が形成されると予想されます。イノベーションと市場拡大に対するこのような総合的なアプローチがこの分野の成長軌道を支えており、これらの主要プレーヤーが牛結核診断市場の最前線に君臨し続けることを確実にしています。

目次

第1章 序文

  • 分析内容
    • 分析の目的
    • 対象者
    • 主な提供内容
  • 市場セグメンテーション
  • 分析手法
    • フェーズⅠ：二次調査
    • フェーズⅡ：一次調査
    • フェーズⅢ：有識者レビュー
    • 前提条件
    • 採用したアプローチ

第2章 エグゼクティブサマリー

第3章 牛結核診断市場：競合分析

  • 主要ベンダーの市場ポジショニング
  • ベンダーが採用した戦略
  • 主要な産業戦略

第4章 牛結核診断市場：マクロ分析と市場力学

  • イントロダクション
  • 世界の牛結核診断市場 (金額ベース、2022～2032年)
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析
  • ポーターのファイブフォースモデル
    • サプライヤーパワー
    • バイヤーパワー
    • 代替品の脅威
    • 新規参入業者の脅威
    • 競争企業間の敵対関係
  • PESTEL分析
    • 政治的情勢
    • 経済的情勢
    • 技術的情勢
    • 法的情勢
    • 社会的情勢

第5章 牛結核診断市場：種類別 (2022～2032年)

  • 市場概要
  • 成長・収益分析：2023 vs 2032
  • 市場セグメンテーション
    • 製品
    • サービス
      • ツベルクリン皮膚テスト
      • 血液検査
      • 分子診断検査

第6章 牛結核診断市場：試料の種類別 (2022～2032年)

  • 市場概要
  • 成長・収益分析：2023 vs 2032
  • 市場セグメンテーション
    • 血液試料
    • 鼻腔スワブ
    • 組織試料
    • その他の試料

第7章 牛結核診断市場：最終用途別 (2022～2032年)

  • 市場概要
  • 成長・収益分析：2023 vs 2032
  • 市場セグメンテーション
    • 動物病院
    • 研究機関
    • 獣医用診断検査室
    • 畜産農場・牧場

第8章 北米の牛結核診断市場 (2022～2032年)

  • 市場概要
  • 牛結核診断市場：種類別 (2022～2032年)
  • 牛結核診断市場：試料の種類別 (2022～2032年)
  • 牛結核診断市場：最終用途別 (2022～2032年)
  • 牛結核診断市場：地域別 (2022～2032年)
    • 北米
      • 米国
      • カナダ
      • その他北米地域

第9章 英国・EU諸国の牛結核診断市場 (2022～2032年)

  • 市場概要
  • 牛結核診断市場：種類別 (2022～2032年)
  • 牛結核診断市場：試料の種類別 (2022～2032年)
  • 牛結核診断市場：最終用途別 (2022～2032年)
  • 牛結核診断市場：地域別 (2022～2032年)
    • 英国・EU諸国
      • 英国
      • ドイツ
      • スペイン
      • イタリア
      • フランス
      • その他欧州地域

第10章 アジア太平洋の牛結核診断市場 (2022～2032年)

  • 市場概要
  • 牛結核診断市場：種類別 (2022～2032年)
  • 牛結核診断市場：試料の種類別 (2022～2032年)
  • 牛結核診断市場：最終用途別 (2022～2032年)
  • 牛結核診断市場：地域別 (2022～2032年)
    • アジア太平洋
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋地域

第11章 ラテンアメリカの牛結核診断市場 (2022～2032年)

  • 市場概要
  • 牛結核診断市場：種類別 (2022～2032年)
  • 牛結核診断市場：試料の種類別 (2022～2032年)
  • 牛結核診断市場：最終用途別 (2022～2032年)
  • 牛結核診断市場：地域別 (2022～2032年)
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • その他ラテンアメリカ地域

第12章 中東・アフリカの牛結核診断市場 (2022～2032年)

  • 市場概要
  • 牛結核診断市場：種類別 (2022～2032年)
  • 牛結核診断市場：試料の種類別 (2022～2032年)
  • 牛結核診断市場：最終用途別 (2022～2032年)
  • 牛結核診断市場：地域別 (2022～2032年)
    • 中東・アフリカ
      • GCC
      • アフリカ
      • その他中東・アフリカ地域

第13章 企業プロファイル

  • Bio-Rad Laboratories
  • Chembio Diagnostics
  • Enfer
  • IDEXX Laboratories
  • IDVet
  • LIONEX
  • PBD Biotech
  • QIAGEN
  • Thermo Fisher Scientific
  • ZENDAL
  • その他の主要企業
図表

List of Tables

  • TABLE 1 Global Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 2 Global Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 3 Global Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 4 Global Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 5 Global Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 6 Global Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 7 North America Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 8 North America Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 9 North America Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 10 North America Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 11 North America Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 12 North America Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 13 U.S. Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 14 U.S. Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 15 U.S. Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 16 U.S. Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 17 U.S. Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 18 U.S. Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 19 Canada Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 20 Canada Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 21 Canada Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 22 Canada Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 23 Canada Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 24 Canada Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 25 Rest of North America Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 26 Rest of North America Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 27 Rest of North America Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 28 Rest of North America Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 29 Rest of North America Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 30 Rest of North America Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 31 UK and European Union Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 32 UK and European Union Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 33 UK and European Union Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 34 UK and European Union Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 35 UK and European Union Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 36 UK and European Union Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 37 UK Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 38 UK Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 39 UK Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 40 UK Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 41 UK Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 42 UK Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 43 Germany Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 44 Germany Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 45 Germany Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 46 Germany Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 47 Germany Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 48 Germany Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 49 Spain Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 50 Spain Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 51 Spain Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 52 Spain Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 53 Spain Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 54 Spain Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 55 Italy Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 56 Italy Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 57 Italy Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 58 Italy Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 59 Italy Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 60 Italy Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 61 France Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 62 France Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 63 France Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 64 France Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 65 France Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 66 France Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 67 Rest of Europe Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 68 Rest of Europe Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 69 Rest of Europe Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 70 Rest of Europe Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 71 Rest of Europe Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 72 Rest of Europe Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 73 Asia Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 74 Asia Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 75 Asia Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 76 Asia Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 77 Asia Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 78 Asia Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 79 China Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 80 China Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 81 China Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 82 China Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 83 China Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 84 China Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 85 Japan Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 86 Japan Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 87 Japan Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 88 Japan Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 89 Japan Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 90 Japan Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 91 India Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 92 India Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 93 India Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 94 India Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 95 India Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 96 India Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 97 Australia Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 98 Australia Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 99 Australia Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 100 Australia Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 101 Australia Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 102 Australia Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 103 South Korea Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 104 South Korea Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 105 South Korea Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 106 South Korea Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 107 South Korea Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 108 South Korea Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 109 Latin America Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 110 Latin America Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 111 Latin America Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 112 Latin America Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 113 Latin America Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 114 Latin America Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 115 Brazil Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 116 Brazil Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 117 Brazil Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 118 Brazil Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 119 Brazil Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 120 Brazil Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 121 Mexico Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 122 Mexico Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 123 Mexico Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 124 Mexico Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 125 Mexico Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 126 Mexico Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 127 Rest of Latin America Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 128 Rest of Latin America Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 129 Rest of Latin America Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 130 Rest of Latin America Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 131 Rest of Latin America Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 132 Rest of Latin America Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 133 Middle East and Africa Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 134 Middle East and Africa Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 135 Middle East and Africa Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 136 Middle East and Africa Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 137 Middle East and Africa Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 138 Middle East and Africa Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 139 GCC Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 140 GCC Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 141 GCC Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 142 GCC Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 143 GCC Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 144 GCC Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 145 Africa Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 146 Africa Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 147 Africa Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 148 Africa Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 149 Africa Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 150 Africa Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)
  • TABLE 151 Rest of Middle East and Africa Bovine Tuberculosis Diagnosis Market By Type, 2022-2032, USD (Million)
  • TABLE 152 Rest of Middle East and Africa Bovine Tuberculosis Diagnosis Market By Services, 2022-2032, USD (Million)
  • TABLE 153 Rest of Middle East and Africa Bovine Tuberculosis Diagnosis Market By Tuberculin skin test, 2022-2032, USD (Million)
  • TABLE 154 Rest of Middle East and Africa Bovine Tuberculosis Diagnosis Market By Blood-based assay test, 2022-2032, USD (Million)
  • TABLE 155 Rest of Middle East and Africa Bovine Tuberculosis Diagnosis Market By Sample Type, 2022-2032, USD (Million)
  • TABLE 156 Rest of Middle East and Africa Bovine Tuberculosis Diagnosis Market By End use, 2022-2032, USD (Million)

List of Figures

  • FIG. 1 Global Bovine Tuberculosis Diagnosis Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Bovine Tuberculosis Diagnosis Market: Quality Assurance
  • FIG. 5 Global Bovine Tuberculosis Diagnosis Market, By Type, 2023
  • FIG. 6 Global Bovine Tuberculosis Diagnosis Market, By Sample Type, 2023
  • FIG. 7 Global Bovine Tuberculosis Diagnosis Market, By End use, 2023
  • FIG. 8 Global Bovine Tuberculosis Diagnosis Market, By Geography, 2023
  • FIG. 9 Market Geographical Opportunity Matrix - Global Bovine Tuberculosis Diagnosis Market, 2023
  • FIG. 10Market Positioning of Key Bovine Tuberculosis Diagnosis Market Players, 2023
  • FIG. 11Global Bovine Tuberculosis Diagnosis Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032
  • FIG. 12 Global Bovine Tuberculosis Diagnosis Market, By Type, 2023 Vs 2032, %
  • FIG. 13 Global Bovine Tuberculosis Diagnosis Market, By Sample Type, 2023 Vs 2032, %
  • FIG. 14 Global Bovine Tuberculosis Diagnosis Market, By End use, 2023 Vs 2032, %
  • FIG. 15 U.S. Bovine Tuberculosis Diagnosis Market (US$ Million), 2022 - 2032
  • FIG. 16 Canada Bovine Tuberculosis Diagnosis Market (US$ Million), 2022 - 2032
  • FIG. 17 Rest of North America Bovine Tuberculosis Diagnosis Market (US$ Million), 2022 - 2032
  • FIG. 18 UK Bovine Tuberculosis Diagnosis Market (US$ Million), 2022 - 2032
  • FIG. 19 Germany Bovine Tuberculosis Diagnosis Market (US$ Million), 2022 - 2032
  • FIG. 20 Spain Bovine Tuberculosis Diagnosis Market (US$ Million), 2022 - 2032
  • FIG. 21 Italy Bovine Tuberculosis Diagnosis Market (US$ Million), 2022 - 2032
  • FIG. 22 France Bovine Tuberculosis Diagnosis Market (US$ Million), 2022 - 2032
  • FIG. 23 Rest of Europe Bovine Tuberculosis Diagnosis Market (US$ Million), 2022 - 2032
  • FIG. 24 China Bovine Tuberculosis Diagnosis Market (US$ Million), 2022 - 2032
  • FIG. 25 Japan Bovine Tuberculosis Diagnosis Market (US$ Million), 2022 - 2032
  • FIG. 26 India Bovine Tuberculosis Diagnosis Market (US$ Million), 2022 - 2032
  • FIG. 27 Australia Bovine Tuberculosis Diagnosis Market (US$ Million), 2022 - 2032
  • FIG. 28 South Korea Bovine Tuberculosis Diagnosis Market (US$ Million), 2022 - 2032
  • FIG. 29 Rest of Asia Bovine Tuberculosis Diagnosis Market (US$ Million), 2022 - 2032
  • FIG. 30 Brazil Bovine Tuberculosis Diagnosis Market (US$ Million), 2022 - 2032
  • FIG. 31 Mexico Bovine Tuberculosis Diagnosis Market (US$ Million), 2022 - 2032
  • FIG. 32 Rest of Latin America Bovine Tuberculosis Diagnosis Market (US$ Million), 2022 - 2032
  • FIG. 33 GCC Bovine Tuberculosis Diagnosis Market (US$ Million), 2022 - 2032
  • FIG. 34 Africa Bovine Tuberculosis Diagnosis Market (US$ Million), 2022 - 2032
  • FIG. 35 Rest of Middle East and Africa Bovine Tuberculosis Diagnosis Market (US$ Million), 2022 - 2032
目次
Product Code: 140821-11-24

The bovine tuberculosis diagnosis market is expected to grow at a CAGR of 7.7% during the forecast period of 2024 to 2032. Bovine tuberculosis (bTB) is a chronic disease among cattle caused by the bacterium Mycobacterium bovis, closely related to the bacteria that causes tuberculosis in humans. This disease has a significant impact on livestock worldwide due to its ability to spread rapidly among herds and its potential for transmission to humans, primarily through unpasteurized milk and direct contact. The diagnosis of bTB is crucial for effective management and control of the disease, involving skin tests, blood tests, and more advanced methods such as PCR and interferon-gamma release assays. The market for bovine tuberculosis diagnosis is driven by the need to maintain herd health, comply with trade regulations, and prevent zoonotic transmission of the disease.

Drivers

Increasing Prevalence of Bovine Tuberculosis

The rising incidence of bovine tuberculosis worldwide is a primary driver for the diagnostic market. Regions with extensive dairy and beef industries, particularly where systematic control programs are not robust, witness higher rates of bTB infections. This increase in prevalence necessitates regular and widespread testing within herds to prevent spread, supporting the growth of the diagnostic market.

Regulatory Mandates and Control Programs

Governments and international bodies have implemented strict regulations and control programs requiring regular testing of cattle for tuberculosis. These regulatory frameworks are designed to manage and eventually eradicate bTB, especially in countries with significant livestock exports. For instance, the European Union's comprehensive eradication programs mandate regular testing, influencing substantial demand for diagnostic tests in member countries.

Advancements in Diagnostic Technologies

The development of more accurate and faster diagnostic methods, such as molecular diagnostics and enhanced serological techniques, drives market growth. These technologies offer quicker results and higher sensitivity and specificity compared to traditional methods, such as the tuberculin skin test. The integration of advanced diagnostics in routine veterinary care enhances early detection and management of bTB, propelling the diagnostic market forward.

Restraint

High Cost and Complexity of Diagnostic Tests

Despite the advances in diagnostic technologies, the high cost and complexity associated with these tests act as a major restraint. Advanced diagnostic methods like PCR and culture tests require sophisticated equipment and skilled personnel, which are not always available in rural or underdeveloped regions. The economic burden of these tests limits their widespread adoption, particularly in developing countries where livestock production plays a crucial economic role but financial resources are limited. This economic factor significantly hampers the growth of the bovine tuberculosis diagnosis market, as cost-effective solutions are still needed to cater to large-scale and regular testing demands.

Market Segmentation by Sample Type

The bovine tuberculosis diagnosis market is segmented by sample type into blood samples, nasal swabs, tissue samples, and other samples. Blood samples are anticipated to exhibit the highest Compound Annual Growth Rate (CAGR) due to their ease of collection and the ability to be used in a variety of tests, including advanced serological and molecular diagnostics, which are gaining traction for their sensitivity and specificity. Tissue samples, often obtained post-mortem or via biopsy, are expected to generate the highest revenue within the market. This is attributed to their critical role in definitive diagnosis through culture tests and histopathology, which, despite being more invasive and requiring sophisticated handling, provide conclusive evidence of the disease. The need for accurate diagnosis in suspected cases of bovine tuberculosis drives the demand for these sample types, reflecting their substantial share in market revenues. Overall, advancements in diagnostic technologies that increase the efficiency and accuracy of tests using these samples are crucial in pushing their adoption and growth within the market.

Market Segmentation by End Use

In the market segmentation by end use, the bovine tuberculosis diagnosis market is categorized into veterinary hospitals, research institutes, veterinary diagnostic laboratories, and livestock farms and ranches. Veterinary diagnostic laboratories are projected to lead in terms of CAGR owing to their specialized capabilities in handling and analyzing diverse sample types and their critical role in disease surveillance and outbreak response. Livestock farms and ranches are expected to account for the highest revenue segment. This segment's dominance can be attributed to the high dependency on maintaining disease-free herds for economic viability, which compels continuous and extensive testing practices. As the primary sites for potential outbreaks, farms and ranches invest significantly in regular screenings to prevent the spread of the disease, thus driving substantial revenues in the market. The integration of advanced diagnostics at the point of care in livestock settings, although growing, is still underpenetrated, offering significant potential for market expansion. These dynamics underscore the critical role of both segments in the broader ecosystem of bovine tuberculosis management.

Regional Insight

The bovine tuberculosis diagnosis market's geographic segmentation reveals distinct trends and variances across regions. North America is expected to exhibit the highest Compound Annual Growth Rate (CAGR) due to advanced agricultural practices, stringent regulatory frameworks, and heightened awareness regarding zoonotic diseases. This region's proactive stance on bovine tuberculosis management through comprehensive surveillance and control programs contributes significantly to its growth dynamics. Conversely, Asia-Pacific is anticipated to account for the highest revenue percentage in the market. The substantial livestock populations in countries like India and China, coupled with increasing government initiatives to enhance animal health standards, drive substantial market revenues. This region's emphasis on improving livestock productivity to meet the rising demand for dairy and meat products solidifies its dominant revenue position. Additionally, the market is further influenced by evolving regulations, economic development, and technological adoption patterns, which vary significantly across Europe, Latin America, and the Middle East and Africa, each contributing to the global landscape of bovine tuberculosis diagnosis with differing growth potentials and challenges.

Competitive Landscape

In the competitive landscape, key players such as Bio-Rad Laboratories, Chembio Diagnostics, Enfer, IDEXX Laboratories, IDVet, LIONEX, PBD Biotech, QIAGEN, Thermo Fisher Scientific, and ZENDAL are intensively competing and driving innovations within the bovine tuberculosis diagnosis market. These companies are strategically focusing on expanding their product portfolios, advancing diagnostic technologies, and entering new markets through partnerships, acquisitions, and increased R&D investments. For instance, in 2022, Thermo Fisher Scientific reported significant revenue growth from its animal health solutions sector, leveraging its extensive distribution network and technological prowess to capture a larger market share. Similarly, QIAGEN has been active in enhancing its diagnostic assays and platforms, aiming to offer more precise and quicker testing solutions. The forecast period from 2024 to 2032 is expected to witness continued efforts from these companies in enhancing diagnostic accuracy and reducing turnaround times. Strategies such as collaborations with governmental and regional animal health organizations, as well as participation in global health programs, are anticipated to be pivotal. The emphasis on integrating digital tools and AI into diagnostics is also expected to shape competitive strategies, as companies seek to offer differentiated and value-added services to veterinary practices worldwide. This holistic approach to innovation and market expansion underpins the sector's growth trajectory, ensuring these key players remain at the forefront of the bovine tuberculosis diagnosis market.

Historical & Forecast Period

This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Bovine Tuberculosis Diagnosis market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Bovine Tuberculosis Diagnosis market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

  • Market Segmentation
  • Type
    • Product
    • Services
  • Tuberculin skin test
  • Comparative cervical test (CCT)
  • Single intradermal test (SIT)
  • Single cervical test (SCT) or caudal (tail) fold test (CFT)
  • Blood-based assay test
  • Gamma interferon (IFN-Y) assay
  • Enzyme-linked immunosorbent assay (ELISA)
  • Other blood-based assay tests
  • Molecular diagnostics tests
  • Sample Type
    • Blood sample
    • Nasal swabs
    • Tissue sample
    • Other samples
  • End use
    • Veterinary hospitals
    • Research institutes
    • Veterinary diagnostic laboratories
    • Livestock farms and ranches
  • Region Segment (2022-2032; US$ Million)
  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Bovine Tuberculosis Diagnosis market?
  • What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2032.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Bovine Tuberculosis Diagnosis market?
  • Which is the largest regional market for Bovine Tuberculosis Diagnosis market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Bovine Tuberculosis Diagnosis market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Bovine Tuberculosis Diagnosis market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Bovine Tuberculosis Diagnosis Market
  • 2.2. Global Bovine Tuberculosis Diagnosis Market, By Type, 2023 (US$ Million)
  • 2.3. Global Bovine Tuberculosis Diagnosis Market, By Sample Type, 2023 (US$ Million)
  • 2.4. Global Bovine Tuberculosis Diagnosis Market, By End use, 2023 (US$ Million)
  • 2.5. Global Bovine Tuberculosis Diagnosis Market, By Geography, 2023 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2023

3. Bovine Tuberculosis Diagnosis Market: Competitive Analysis

  • 3.1. Market Positioning of Key Bovine Tuberculosis Diagnosis Market Vendors
  • 3.2. Strategies Adopted by Bovine Tuberculosis Diagnosis Market Vendors
  • 3.3. Key Industry Strategies

4. Bovine Tuberculosis Diagnosis Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Bovine Tuberculosis Diagnosis Market Value, 2022 - 2032, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 5.3. Market Segmentation
    • 5.3.1. Product
    • 5.3.2. Services
      • 5.3.2.1. Tuberculin skin test
        • 5.3.2.1.1. Comparative cervical test (CCT)
        • 5.3.2.1.2. Single intradermal test (SIT)
        • 5.3.2.1.3. Single cervical test (SCT) or caudal (tail) fold test (CFT)
      • 5.3.2.2. Blood-based assay test
        • 5.3.2.2.1. Gamma interferon (IFN-Y) assay
        • 5.3.2.2.2. Enzyme-linked immunosorbent assay (ELISA)
        • 5.3.2.2.3. Other blood-based assay tests
      • 5.3.2.3. Molecular diagnostics tests

6. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 6.3. Market Segmentation
    • 6.3.1. Blood sample
    • 6.3.2. Nasal swabs
    • 6.3.3. Tissue sample
    • 6.3.4. Other samples

7. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 7.3. Market Segmentation
    • 7.3.1. Veterinary hospitals
    • 7.3.2. Research institutes
    • 7.3.3. Veterinary diagnostic laboratories
    • 7.3.4. Livestock farms and ranches

8. North America Bovine Tuberculosis Diagnosis Market, 2022-2032, USD (Million)

  • 8.1. Market Overview
  • 8.2. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
  • 8.3. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
  • 8.4. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)
  • 8.5.Bovine Tuberculosis Diagnosis Market: By Region, 2022-2032, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
        • 8.5.1.1.2. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
        • 8.5.1.1.3. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
        • 8.5.1.2.2. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
        • 8.5.1.2.3. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
        • 8.5.1.3.2. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
        • 8.5.1.3.3. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)

9. UK and European Union Bovine Tuberculosis Diagnosis Market, 2022-2032, USD (Million)

  • 9.1. Market Overview
  • 9.2. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
  • 9.3. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
  • 9.4. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)
  • 9.5.Bovine Tuberculosis Diagnosis Market: By Region, 2022-2032, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.1.2. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
        • 9.5.1.1.3. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.2.2. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
        • 9.5.1.2.3. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.3.2. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
        • 9.5.1.3.3. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.4.2. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
        • 9.5.1.4.3. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.5.2. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
        • 9.5.1.5.3. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.6.2. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
        • 9.5.1.6.3. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)

10. Asia Pacific Bovine Tuberculosis Diagnosis Market, 2022-2032, USD (Million)

  • 10.1. Market Overview
  • 10.2. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
  • 10.3. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
  • 10.4. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)
  • 10.5.Bovine Tuberculosis Diagnosis Market: By Region, 2022-2032, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.1.2. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
        • 10.5.1.1.3. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.2.2. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
        • 10.5.1.2.3. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.3.2. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
        • 10.5.1.3.3. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.4.2. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
        • 10.5.1.4.3. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.5.2. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
        • 10.5.1.5.3. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.6.2. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
        • 10.5.1.6.3. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)

11. Latin America Bovine Tuberculosis Diagnosis Market, 2022-2032, USD (Million)

  • 11.1. Market Overview
  • 11.2. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
  • 11.3. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
  • 11.4. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)
  • 11.5.Bovine Tuberculosis Diagnosis Market: By Region, 2022-2032, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
        • 11.5.1.1.2. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
        • 11.5.1.1.3. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
        • 11.5.1.2.2. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
        • 11.5.1.2.3. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
        • 11.5.1.3.2. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
        • 11.5.1.3.3. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)

12. Middle East and Africa Bovine Tuberculosis Diagnosis Market, 2022-2032, USD (Million)

  • 12.1. Market Overview
  • 12.2. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
  • 12.3. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
  • 12.4. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)
  • 12.5.Bovine Tuberculosis Diagnosis Market: By Region, 2022-2032, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
        • 12.5.1.1.2. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
        • 12.5.1.1.3. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
        • 12.5.1.2.2. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
        • 12.5.1.2.3. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Bovine Tuberculosis Diagnosis Market: By Type, 2022-2032, USD (Million)
        • 12.5.1.3.2. Bovine Tuberculosis Diagnosis Market: By Sample Type, 2022-2032, USD (Million)
        • 12.5.1.3.3. Bovine Tuberculosis Diagnosis Market: By End use, 2022-2032, USD (Million)

13. Company Profile

  • 13.1. Bio-Rad Laboratories
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Chembio Diagnostics
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Enfer
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. IDEXX Laboratories
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. IDVet
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. LIONEX
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. PBD Biotech
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. QIAGEN
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Thermo Fisher Scientific
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. ZENDAL
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
  • 13.11. Other Notable Players
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Portfolio
    • 13.11.4. Strategic Initiatives